Title : Emergence of ceftazidime-avibactam resistance due to a novel blaKPC-2 mutation during treatment of carbapenem-resistant Klebsiella pneumoniae infections.

Pub. Date : 2022 May

PMID : 35461077






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: We report a case of emergence of CAZ-AVI resistance in ST 11 KPC-2-producing K. pneumoniae (KP-HX1016) during 14 days of exposure with CZA-AVI. avibactam, ceftazidime drug combination carbapenem-hydrolyzing beta-lactamase KPC-2 Klebsiella pneumoniae